$2.94
0.01000.34%
At Close: -
$2.94
00.00%
After Hours: Sep 20, 4:04 PM EDT
15 minutes delayed
Marker Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Marker Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.25 | $-0.43 | 41.9 % |
Mar 2023 | 2023-05-15 | $-0.57 | $-0.80 | 28.7 % |
Dec 2022 | 2023-03-22 | $-0.45 | $-1.60 | 71.9 % |
Sep 2022 | 2022-11-10 | $-0.80 | $-1.20 | 33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2022 | 2022-11-10 | $3.95M | $270.00K | 1363.0 % |
Jun 2022 | 2022-08-11 | $790.51K | $670.00K | 18.0 % |
Marker Therapeutics (MRKR) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.25, which beat the estimate of $-0.43.
The Actual Revenue was $1.2M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.